DUBLIN--(BUSINESS WIRE)--The "Cough, Cold and Allergy (Hay Fever) Remedies in the US" report has been added to ResearchAndMarkets.com's offering. Over a year since FDA approval to switch to the OTC market, allergy nasal spray Astepro is now available at retail locations. Astepro is the first and only 24-hour over-the-counter antihistamine nasal spray that is steroid-free. The 0.15% strength of its active ingredient, azelastine, was the only formulation to be approved for the treatment of rhinitis, and its 0.1% strength formulation for children younger than six remains a prescription product. The Cough, Cold and Allergy (Hay Fever) Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change. Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Bayer's Astepro hits the US market following its successful Rx-to-OTC switch Still wary about COVID-19, some consumers are eager to pre-emptively treat symptoms PROSPECTS AND OPPORTUNITIES
Potential for longer flu seasons could create greater opportunity for year-round sales
Antihistamines/allergy remedies set to perform well over the forecast period Herbal/natural trend set to expand, especially for paediatric products CONSUMER HEALTH IN THE US
Consumer health in 2022: The big picture
What next for consumer health?
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Summary 1 OTC: Switches 2021-2022
For more information about this report visit https://www.researchandmarkets.com/r/fkdcok